Dr. Binita Shah was awarded her MD and a Masters of Science in Clinical Investigation from NYU School of Medicine. After her Interventional Cardiology fellowship, she completed two years of a post-doctoral research fellowship with funding from the American College of Cardiology Foundation and the NIH T32 Program.
Dr. Shah joined the Interventional Cardiology faculty at NYU and its affiliate, the Manhattan Veterans Affairs Hospital, in 2012. Dr. Shah is currently Assistant Professor of Medicine and Associate Director of Research in the Cardiac Catheterization Laboratory at NYU. She is also Associate Director Cardiac Catheterization Laboratory and Director of the Transcatheter Valve Program at the Manhattan VA Hospital. Dr. Shah conducts clinical translational research and utilizes a multi-disciplinary approach to the treatment of coronary artery disease and acute coronary syndrome with a focus on optimization of the underlying inflammatory and glucometabolic milieu. She was a recipient of a grant from the American Heart Association Clinical Research Program and is principal investigator of the recently completed randomized COLCHICINE-PCI trial (funded through a VA Career Development Award) and the ongoing CLEAR SYNERGY Biospecimen Substudy and ColCorona-US Trial (funded through NIH/NHLBI R01).
Dr. Shah serves on multiple national committees including the Society of Cardiovascular Angiography and Interventions Emerging Leadership Mentorship program, American Heart Association Scientific Sessions Planning program, and American College of Cardiology NCDR STS/TVT Registry Research and Publications committees. Dr. Shah is also Associate Editor for Circulation Cardiovascular Intervention and serves on the Society of Cardiovascular Angiography and Interventions Board of Trustees.